Literature DB >> 18951504

Treatment of fragile-X-associated tremor/ataxia syndrome with deep brain stimulation.

Joseph M Ferrara, Octavian R Adam, William G Ondo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18951504     DOI: 10.1002/mds.22354

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  6 in total

1.  Which approach is better: bilateral versus unilateral thalamic deep brain stimulation in patients with fragile X-associated tremor ataxia syndrome.

Authors:  R Mehanna; I Itin
Journal:  Cerebellum       Date:  2014-04       Impact factor: 3.847

2.  Measurement of evoked potentials during thalamic deep brain stimulation.

Authors:  Alexander R Kent; Brandon D Swan; David T Brocker; Dennis A Turner; Robert E Gross; Warren M Grill
Journal:  Brain Stimul       Date:  2014-10-05       Impact factor: 8.955

3.  Deep brain stimulation in uncommon tremor disorders: indications, targets, and programming.

Authors:  Carlo Alberto Artusi; Ashar Farooqi; Alberto Romagnolo; Luca Marsili; Roberta Balestrino; Leonard L Sokol; Lily L Wang; Maurizio Zibetti; Andrew P Duker; George T Mandybur; Leonardo Lopiano; Aristide Merola
Journal:  J Neurol       Date:  2018-03-06       Impact factor: 4.849

Review 4.  Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.

Authors:  Randi Hagerman; Paul Hagerman
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

5.  Deep brain stimulation for tremor associated with underlying ataxia syndromes: a case series and discussion of issues.

Authors:  Genko Oyama; Amanda Thompson; Kelly D Foote; Natlada Limotai; Muhammad Abd-El-Barr; Nicholas Maling; Irene A Malaty; Ramon L Rodriguez; Sankarasubramoney H Subramony; Tetsuo Ashizawa; Michael S Okun
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2014-07-09

Review 6.  Deep brain stimulation for the treatment of uncommon tremor syndromes.

Authors:  Adolfo Ramirez-Zamora; Michael S Okun
Journal:  Expert Rev Neurother       Date:  2016-06-09       Impact factor: 4.618

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.